Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity

Systems established for active drug safety monitoring and management of drug-resistant TB should be leveraged to ensure comprehensive surveillance for active toxicity monitoring during scale-up of newer antiretroviral regimens.

Detalles Bibliográficos
Autores principales: Stevens, Lisa, Perry, Kelly E., Moide, Iakuna, Kaemala, Francil, Nankinga, Justine, Innes, Anh L., Mogaba, Ignatius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2022
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053160/
https://www.ncbi.nlm.nih.gov/pubmed/35487562
http://dx.doi.org/10.9745/GHSP-D-21-00595
Descripción
Sumario:Systems established for active drug safety monitoring and management of drug-resistant TB should be leveraged to ensure comprehensive surveillance for active toxicity monitoring during scale-up of newer antiretroviral regimens.

Ejemplares similares